long intergenic non-protein coding RNA 2036Genealiases: []
Q-omics provides the consensus-scored LINC02036 profile across patient tissues and cancer cell-line models. LINC02036 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in LUAD. Among the 18 cancer types available for tumor–normal comparison, LINC02036 is differentially expressed in 12, with the highest sampling consensus in HNSC. Additionally, LINC02036 RNA expression shows 12,370 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight LUAD, HNSC, and TGCT as cancer lineages where LINC02036 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02036 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02036 survival associations across molecular data types. LINC02036 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02036 RNA expression–survival associations across cancer types. High LINC02036 expression shows unfavorable associations in LGG and ACC, but favorable associations in LUAD, KIRC, UVM and HNSC. The LUAD Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify LUAD as the clearest survival context for LINC02036 RNA expression.
This table summarizes LINC02036 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02036. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02036 shows lower tumor expression in HNSC, KICH and THCA and higher tumor expression in KIRC, LUAD and BRCA. The HNSC box plot shows higher LINC02036 RNA expression in normal versus tumor tissue (log2 FC = −1.011, t-test p < 0.001).
This table shows molecular features associated with LINC02036 in patient tissues and cancer cell lines. In patient samples, LINC02036 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
